FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386283281> ?p ?o ?g. }

• W4386283281 endingPage "2814" @default.
• W4386283281 startingPage "2814" @default.
• W4386283281 abstract "Background: We aimed to investigate the association between kidney stones and polycystic ovarian syndrome (PCOS). Materials and methods: In a cross-sectional study, data from the Tehran Lipid and Glucose Study (TLGS) were used to investigate the risk of kidney stones in women with Polycystic Ovary Syndrome (PCOS). Four distinct phenotypes of PCOS, as defined by the Rotterdam criteria, were examined in a sample of 520 women and compared to a control group of 1638 eumenorrheic non-hirsute healthy women. Univariate and multivariable logistic regression models were employed for analysis. The four PCOS phenotypes were classified as follows: Phenotype A, characterized by the presence of all three PCOS features (anovulation (OA), hyperandrogenism (HA), and polycystic ovarian morphology on ultrasound (PCOM)); Phenotype B, characterized by the presence of anovulation and hyperandrogenism; Phenotype C, characterized by the presence of hyperandrogenism and polycystic ovarian morphology on ultrasound; and Phenotype D, characterized by the presence of anovulation and polycystic ovarian morphology on ultrasound. Results: The prevalence of a history of kidney stones was found to be significantly higher in women with Polycystic Ovary Syndrome (PCOS) compared to healthy controls (12.5% vs. 7.7%, p = 0.001). This increased prevalence was observed across all PCOS phenotypes (p < 0.001). After adjusting for potential risk factors, including age, family history of kidney stones, waist-to-height ratio, total cholesterol, and low-density lipoprotein, the odds ratio for kidney stones in women with PCOS was found to be 1.59 [95% CI: 1.12–2.25, p = 0.01], indicating a 59% increase in risk compared to healthy women. Women with PCOS Phenotype A [OR: 1.97, 95% CI: 1.09–3.55, p = 0.02] and Phenotype D [OR: 3.03, 95% CI: 1.24–7.41, p = 0.01] were found to be at a higher risk for kidney stones. Conclusion: Women with Polycystic Ovary Syndrome (PCOS), particularly those exhibiting menstrual irregularities and polycystic ovarian morphology on ultrasound (PCOM), have been found to be two to three times more likely to develop kidney stones. This increased prevalence should be taken into consideration when providing preventive care and counseling to these individuals." @default.
• W4386283281 created "2023-08-31" @default.
• W4386283281 creator A5032339382 @default.
• W4386283281 creator A5037842594 @default.
• W4386283281 creator A5038229461 @default.
• W4386283281 creator A5044112035 @default.
• W4386283281 creator A5053659013 @default.
• W4386283281 creator A5080500381 @default.
• W4386283281 date "2023-08-30" @default.
• W4386283281 modified "2023-10-16" @default.
• W4386283281 title "The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)" @default.
• W4386283281 cites W1965603100 @default.
• W4386283281 cites W1976843335 @default.
• W4386283281 cites W1986902166 @default.
• W4386283281 cites W1996641377 @default.
• W4386283281 cites W1998040944 @default.
• W4386283281 cites W2007463346 @default.
• W4386283281 cites W2015252890 @default.
• W4386283281 cites W2017579894 @default.
• W4386283281 cites W2023064342 @default.
• W4386283281 cites W2024028239 @default.
• W4386283281 cites W2025210561 @default.
• W4386283281 cites W2044702943 @default.
• W4386283281 cites W2044970382 @default.
• W4386283281 cites W2059986623 @default.
• W4386283281 cites W2065989691 @default.
• W4386283281 cites W2068107397 @default.
• W4386283281 cites W2069736363 @default.
• W4386283281 cites W2075589613 @default.
• W4386283281 cites W2081304368 @default.
• W4386283281 cites W2081491461 @default.
• W4386283281 cites W2084139018 @default.
• W4386283281 cites W2087327169 @default.
• W4386283281 cites W2125564127 @default.
• W4386283281 cites W2125629927 @default.
• W4386283281 cites W2139209113 @default.
• W4386283281 cites W2163069137 @default.
• W4386283281 cites W2178623168 @default.
• W4386283281 cites W2195301206 @default.
• W4386283281 cites W2314572539 @default.
• W4386283281 cites W2400134291 @default.
• W4386283281 cites W2415358267 @default.
• W4386283281 cites W2481127295 @default.
• W4386283281 cites W2525527370 @default.
• W4386283281 cites W2534161646 @default.
• W4386283281 cites W2542198397 @default.
• W4386283281 cites W2554050349 @default.
• W4386283281 cites W2588771666 @default.
• W4386283281 cites W2775724704 @default.
• W4386283281 cites W2854044000 @default.
• W4386283281 cites W2872633888 @default.
• W4386283281 cites W2890312960 @default.
• W4386283281 cites W2897478041 @default.
• W4386283281 cites W2923768126 @default.
• W4386283281 cites W2930904966 @default.
• W4386283281 cites W2942698391 @default.
• W4386283281 cites W2947849302 @default.
• W4386283281 cites W2949825098 @default.
• W4386283281 cites W2980378669 @default.
• W4386283281 cites W3015424411 @default.
• W4386283281 cites W3022315549 @default.
• W4386283281 cites W3046872507 @default.
• W4386283281 cites W3112533620 @default.
• W4386283281 cites W4200326176 @default.
• W4386283281 cites W4206946932 @default.
• W4386283281 cites W4214807362 @default.
• W4386283281 cites W4220804318 @default.
• W4386283281 cites W68115163 @default.
• W4386283281 doi "https://doi.org/10.3390/diagnostics13172814" @default.
• W4386283281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37685351" @default.
• W4386283281 hasPublicationYear "2023" @default.
• W4386283281 type Work @default.
• W4386283281 citedByCount "0" @default.
• W4386283281 crossrefType "journal-article" @default.
• W4386283281 hasAuthorship W4386283281A5032339382 @default.
• W4386283281 hasAuthorship W4386283281A5037842594 @default.
• W4386283281 hasAuthorship W4386283281A5038229461 @default.
• W4386283281 hasAuthorship W4386283281A5044112035 @default.
• W4386283281 hasAuthorship W4386283281A5053659013 @default.
• W4386283281 hasAuthorship W4386283281A5080500381 @default.
• W4386283281 hasBestOaLocation W43862832811 @default.
• W4386283281 hasConcept C126322002 @default.
• W4386283281 hasConcept C134018914 @default.
• W4386283281 hasConcept C156957248 @default.
• W4386283281 hasConcept C2777391703 @default.
• W4386283281 hasConcept C2778096610 @default.
• W4386283281 hasConcept C2780186808 @default.
• W4386283281 hasConcept C2780853582 @default.
• W4386283281 hasConcept C2781179581 @default.
• W4386283281 hasConcept C29456083 @default.
• W4386283281 hasConcept C3018442814 @default.
• W4386283281 hasConcept C511355011 @default.
• W4386283281 hasConcept C71924100 @default.
• W4386283281 hasConceptScore W4386283281C126322002 @default.
• W4386283281 hasConceptScore W4386283281C134018914 @default.
• W4386283281 hasConceptScore W4386283281C156957248 @default.
• W4386283281 hasConceptScore W4386283281C2777391703 @default.
• W4386283281 hasConceptScore W4386283281C2778096610 @default.

• next